Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of AZT transplacental carcinogenesis study M990048


CASRN: 30516-87-1

Formula: C10-H13-N5-O4

Synonyms/Common Names

  • 3'-Azido-3'-deoxythymidine
  • AZT Transplacental Carcinogenesis Study (AIDS Initiative)

Long-Term Carcinogenicity

  • 19 months (In Utero)  (C99022)  Completed 
    • TR-522 (NIH Number: 06-4458)  (Peer Review Approval 12/09/2004A )
      Toxicology and Carcinogenesis Studies of Transplacental AZT (CASRN 30516-87-1) in Swiss (CD-1®) Mice (in utero Studies)
    • Mice: Swiss CD-1
    • Carcinogenesis Results
      • Male Mice Clear Evidence 
      • Female Mice No Evidence 
    • Dose: AZT: 50, 100, 200, OR 300 MG/KG/DAY; 25, 25, 36, OR 46 PER GROUP.

Special Studies

  • Toxicokinetic Study (Intravenous; Dosed-Water)  (S0874)  Completed 
    • Female Mice: SWISS CD-1